WHO intensifies Ebola-curbing efforts through drug trial and diagnostic rollout
The World Health Organization (WHO) has taken fresh steps to curb the rising Ebola epidemic in central Africa caused by …
Post
-
-
US-UK pharma trade deal paints a costly economic picture for NHS
The UK-US pharmaceuticals deal could cost the National Health Service (NHS) around £45bn ($60bn) within a decade and divert resources …
-
SK bioscience to lead Gates Foundation-funded ROTOR project
SK bioscience is set to lead the Gates Foundation-fundedResearch Optimization & Trial Outcome Recommender (ROTOR) project, an AI-based platform aimed …
-
The celebrity prescription: star power meets healthcare
For years, Serena Williams was the defining face of women’s tennis. Now, her ongoing alliance with a telehealth company may …
-
European Commission approves Novartis’ Itvisma to treat SMA
The European Commission has granted approval for Novartis’ Itvisma (onasemnogene abeparvovec) as a treatment for children two years and older, …
-
European Commission approves Novartis’ Itvisma to treat SMA
The European Commission has granted approval for Novartis’ Itvisma (onasemnogene abeparvovec) as a treatment for children two years and older, …
-
Outsourcing gap widens: Europe pulls away from US in new drug manufacturing
In 2025, the dose outsourcing gap between the proportion of newly approved biosimilar and innovator products outsourced to European and …
-
Ipsen bolsters rare disease pipeline in €700m Memo takeover
Ipsen has outlaid €700m ($798.4m) to acquire rare disease specialist Memo Therapeutics – enriching its pipeline with a mid-stage clinical …
-
Cell and gene therapy patents: What’s accelerating, what’s lagging behind
Cell and gene therapy patent publications totalled 9,786 in the 12 months to May 2026, a decline of approximately 25% …
-
Podcast: HLTH Europe and BIO key trends rundown
June was a busy month for Pharmaceutical Technology’s editorial team, with journalists attending several key conferences with reach across the …
-
FDA widens Vertex’s Casgevy use for paediatric patients
The US Food and Drug Administration (FDA) has approved expanded use of Vertex Pharmaceuticals’ Casgevy (exagamglogene autotemcel) in children with …
-
Insilico Medicine, Takeda partner on AI-driven drug discovery
Insilico Medicine has entered into a strategic collaboration agreement with Takeda to deploy its AI-based Pharma.AI platform in the discovery …
-
Inocras, AimedBio team up for cancer treatments
US-based precision medicine company Inocras has entered a strategic partnership with South Korean biopharmaceutical company AimedBio to enhance cancer drug …
-
EAN 2026: Bocunebart’s promise as migraine preventive in treatment-refractory patients
On 29 June, at the 12th Congress of the European Academy of Neurology (EAN) 2026, as part of a late-breaking …
-
QuantumCell commits $2.2bn on AlzeCure’s Alzheimer’s platform
Less than a year after emerging from stealth, Danish-based QuantumCell has signed a multi-billion-dollar deal to equip its pipeline with …
